系统性炎症指数在多细胞血病维拉及其预后影响
Ivan Krecak1,2,3, Danijela Lekovic4,5, Isidora Arsenovic4
1Department of Internal Medicine, General Hospital of Sibenik-Knin County, 22000 Sibenik, Croatia.
Journal of clinical medicine
|August 10, 2024
概括
系统性炎症指数 (SII) 是多细胞真血症 (PV) 的一个有价值的预后标志物. 较高的SII水平与血栓形成的风险增加和PV患者的整体存活率降低相关.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 炎症 炎症是一种炎症.
背景情况:
- 多细胞血症真 (PV) 是一种骨髓增殖性瘤.
- 系统性炎症指数 (SII),从中性粒细胞,淋巴细胞和血小板数量得出的,是一个潜在的预后标记.
- 以前的研究表明,SII预测了一般人群中的血栓形成和死亡风险.
研究的目的:
- 评估SII的临床和预后关联在多细胞血真 (PV) 患者.
- 为了确定SII是否可以改进PV中的风险分层.
- 为了将SII的预后性能与其他全血细胞计 (CBC) 参数进行比较.
主要方法:
- 对来自克罗地亚和塞尔维亚血液中心的279名PV患者的回顾性分析.
- 使用绝对中性粒细胞计数 (ANC),绝对淋巴细胞计数 (ALC) 和血小板计数 (ANCxALC/血小板计数) 来计算SII.
- 评估SII,血栓形成时间 (TTT) 和整体存活时间 (OS) 之间的关联.
主要成果:
- 较高的SII与较短的TTT (p = 0.004) 显著相关,特别是动脉血栓事件.
- 较高的SII显著与较短的OS相关 (p < 0.001).
- SII改善了血栓形成和生存风险分层,特别是在60岁以上的PV患者中,表现优于其他CBC指数.
结论:
- 系统性炎症指数 (SII) 是血栓形成和多细胞真菌 (PV) 存活的显著预后因素.
- SII为光伏患者提供了增强的风险分层,补充了现有的风险模型.
- 这些发现支持使用SII来个性化PV治疗策略.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
410
相关概念视频
01:27Disorders of Erythrocytes
914
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
914
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
01:20Vascular Resistance
3.7K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.7K